10 - 11 April, 2024
American Biomanufacturing Summit
SAN FRANCISCO, USA
The American Biomanufacturing Summit is one of the most senior-level conferences and networking events in the industry.
It is designed to provide biopharmaceutical executives with current trends, strategic insights and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain and logistics.
15 - 17 April, 2024
Festival of Biologics San Diego 2024
San Diego, USA
The Festival of Biologics is America’s most exciting biologics event.
We bring together pharma & biotech, academics and research institutes, together with their partners across the value chain. Across antibodies, immunotherapy and biosimilars our participants share research, create new partnerships, and tackle the clinical trials, manufacturing and commercial challenges involved in bringing new therapies to market.
16 - 18 April, 2024
3rd ADC Analytical Development Summit
Boston, USA
The updated ICH Q14 guidance from the FDA revising analytical procedures used for release and stability testing has shown higher product quality expectations from regulatory agencies. As analytical studies become an indispensable requirement to progress the antibody-drug conjugate space forward, so has the need for rigorous analytical methodologies that ensure product quality ahead of regulatory submissions.
The 3rd ADC Analytical Development will provide a technical deep-dive into optimizing physiochemical methods to better quantify DAR and drug distribution, carry out size variant and charge variant analysis, develop bioassays to improve understanding of the potency in a timely fashion, and better utilize impurity assays to measure free-linker drug and overcome species separation, to ensure you are producing a high-quality product within regulatory boundaries.
Join 100+ experts including Daiichi Sankyo, Eli Lilly, ADC Therapeutics, AstraZeneca, and many more to gain an in-depth but holistic overview of all facets of analytical development that ensure you deliver a high-quality, safe and effective ADC that will progress through regulatory checkpoints.
17 - 18 April, 2024
Anglonordic Life Science Conference
London, UK
Anglonordic celebrates a 20-year tradition of attracting leading lifescience investment firms with funds.
Well over 70 investment firms are registered to attend. Based across Europe, these funders have interests in a wide variety of technologies from small molecule discovery through protein technologies to AI applications and healthcare devices.
View the current list of investors attending the 20th Anniversary Anglonordic Life Science Conference.
22 - 23 April, 2024
Pharmaceutical Manufacturing and Packaging Congress (PHARMAP)
Amsterdam, NL
The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2024) welcomes main representatives of the pharmaceutical industry, including top-level management, key technical manufacturing and packaging specialists, supply chain and procurement experts, and heads from manufacturing and packaging pharma technology companies. The Congress is set up to discuss challenges, new trends and present advanced technologies on 22-23, April, 2024 in Amsterdam, the Netherlands.
The PHARMAP platform is a great place to meet key decision makers of the whole value chain. Among the regular participants are Novartis, Takeda, Bayer, Zentiva, Pfizer, Merck and others.
22 - 24 April, 2024
Pre Filled Syringes and Injectable Drug Devices East Coast
Boston, USA
SAE Media Group's 11th Annual Pre-Filled Syringes East Coast Conference will return to Boston in April 2024 to bring you the latest advances in the combination product drug delivery space. As part of SAE’s leading Injectable Drug Delivery Series, the 2024 conference will be bigger and better than ever, bringing you 3 days of expertise, comprising of a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference with morning keynote plenaries and parallel afternoon topic streams addressing the industry’s hottest topics through case studies and industry insights.
This event will not only bring you key insights needed to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in April 2024!
23 - 24 April, 2024
2024 PDA Parenteral Packaging Conference
Copenhagen, DN
The overarching conference theme is “Navigating Complexity: Quality, Innovation, and Supply Chain Resilience in Packaging”.
Packaging development activities for parenteral drugs extend far beyond isolated discussions around just the packaging aspects themselves. It requires a holistic and integrated approach that takes into account the different development interfaces.
In an era marked by unprecedented challenges and rapid advancements, our overarching theme reflects the core issues facing the pharmaceutical packaging industry. Throughout the conference, we will delve into crucial topics such as Container Closure Integrity and deep cold storage, innovation in packaging technologies, and the imperative need for supply chain resilience. Additional agenda topics include regulatory updates, interactions between drugs and primary containers, sustainability, and many more.
Beyond the presentations in the plenary and parallel tracks, this conference also offers guided poster walks, tech talk sessions, an exhibition as well as a networking event allowing you to catch up with friends and peers in the industry.
29 - 30 April, 2024
LSX World Congress 2024
London, UK
The 10th LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core.
The event brings together the CEOs and senior decision makers from the world's most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments - all geared at putting capital and ideas to work to help create the world's future medicines and improve patient outcomes.
